Patent · US Active

Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome

US9526730B2 · kind B2 · utility

2Cited by

125References

13Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas KLEIN · Radolfzell, DE
Maximilian von EYNATTEN · Wiesbaden, DE
Berthold Hocher · Berlin, DE
Michael Mark · Biberach an der Riß, DE
Yuliya SHARKOVSKA · Berlin, DE

Key dates

Filing date	Oct 30, 2015
Grant date	Dec 27, 2016
Priority date	—
Expiry date	Oct 30, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.